WHO WE ARE:

We are a proud, multicultural team deeply inspired to improve outcomes by revolutionizing health care in neurology.
Our research group includes scientists in the areas of neurology, healthcare policy and health services research.

Lidia Moura, M.D., M.P.H.

Principal Investigator – Assistant Professor of Neurology

Dr. Moura is a neurologist and health services researcher in the Department of Neurology at the Massachusetts General Hospital (MGH) and Assistant Professor of Neurology at the Harvard Medical School. At the MGH, she completed a research fellowship in clinical trials, a two-year clinical fellowship in Clinical Neurophysiology and Epilepsy and a one-year clinical fellowship in Advanced General / Autoimmune Neurology to focus on the care of patients with multiple clinical needs.

She holds a Master’s Degree in Public Health from the Harvard T.H. Chan School of Public Health (HSPH) with a concentration in Clinical Effectiveness. She is a PhD student in Population Health Sciences (Epidemiology) at the HSPH and the Harvard Graduate School of Arts and Sciences.

Her work has been primarily sponsored by the American Brain Foundation, the Epilepsy Foundation, the Marriott Foundation, the Harvard University (Harvard Catalyst and Diversity Inclusion and Community Partnership programs), and The National Institutes of Health (National Institute of Aging – Career Development Award).

Dr. Moura’s studies combine the use of medical records, registries, patient-reported surveys and large automated data sets to assess care quality and efficiency in neurology. With strong collaborations at the MGH Mongan Institute for Health Policy and the HSPH, Dr. Moura brings clinical, behavioral and economic perspectives to the NeuroValue lab.

Board of Mentors

<b> John Hsu, MD, MBA </b>
John Hsu, MD, MBA Harvard Medical School
Dr. Hsu is the director of the Program for Clinical Economics and Policy Analysis within the Mongan Institute for Health Policy. He studies innovations in health care financing and delivery, and their effects on medical quality and efficiency. With a background in internal medicine, health services research and clinical epidemiology, and health care finance and management, Dr. Hsu brings clinical, population, and business perspectives to our laboratory.
<b>Sonia Hernandez-Diaz, MD, DrPH </b>
Sonia Hernandez-Diaz, MD, DrPH Harvard T. H. Chan School of Public Health
Sonia Hernandez-Diaz, M.D., Dr.P.H. is the Director of the Pharmacoepidemiology Program and Associate Professor of Epidemiology at the Harvard School of Public Health. Her research focuses on the evaluation of the comparative effectiveness and safety of pharmaceuticals and medical devices, with a special emphasis in pregnant populations.
<b>Joseph P. Newhouse, PhD </b>
Joseph P. Newhouse, PhD Harvard University
Dr. Newhouse is the John D. MacArthur Professor of Health Policy and Management at Harvard University, Director of the Division of Health Policy Research and Education, chair of the Committee on Higher Degrees in Health Policy, and Director of the Interfaculty Initiative in Health Policy. He is a member of the faculties of the Harvard Kennedy School, the Harvard Medical School, the Harvard School of Public Health, and the Faculty of Arts and Sciences, as well as a Faculty Research Associate of the National Bureau of Economic Research.
<b>Deborah Blacker, MD, DrPH </b>
Deborah Blacker, MD, DrPH Harvard T. H. Chan School of Public Health
Dr. Blacker is Deputy Chair and Professor in the Department of Epidemiology at the Harvard T. H. Chan School of Public Health, and Professor of Psychiatry at Harvard Medical School. She directs the Gerontology Research Unit and serves Associate Chief for Research in the Department of Psychiatry. She co-directs the Psychiatric Epidemiology concentration and teaches a course on assessment methods in psychiatric epidemiologic research.
<b>Lee Schwamm, MD </b>
Lee Schwamm, MD Harvard Medical School
Dr. Schwamm is a Professor of Neurology at Harvard Medical School, the Executive Vice Chairman of the Department of Neurology and the
Director of the Mass General Center for TeleHealth. He is a leading researcher in the fields of acute stroke treatment, stroke advocacy, and in the use of TeleHealth and other technology strategies to improve the quality of stroke care.

Board of Advisors

<b>Dan Hoch, MD, PhD </b>
Dan Hoch, MD, PhD Harvard Medical School
Dr. Hoch is a neurologist and Assistant Professor of Neurology at Harvard Medical School.
He is a founding member of the Braintalk Communities, a collection of over 200 separate online support groups for individuals with neurologic disease, a member of the Cooks Branch Initiative, a group founded to promote engaged, empowered and energized “e-Patients“ and a member of the editorial board for The Journal of Participatory Medicine.
<b>Miguel Hernán, MD, DrPH</b>
Miguel Hernán, MD, DrPHHarvard T. H. Chan School of Public Health
Miguel Hernán, MD. DrPH, is the Kolokotrones Professor of Biostatistics and Epidemiology at the Harvard T. H. Chan School of Public Health. He is the author of the textbook “Causal Inference”, an Editor of Epidemiology, an Associate Editor of the American Journal of Epidemiology and of the Journal of the American Statistical Association, and an elected Fellow of the American Association for the Advancement of Science.
<b> Barbara Vickrey, MD, MPH </b>
Barbara Vickrey, MD, MPH Icahn School of Medicine at Mount Sinai
Dr. Vickrey is the System Chair for the Department of Neurology at the Icahn School of Medicine at Mount Sinai.
She is also the associate Director for Research at the Greater Los Angeles VA Parkinson Disease Center and an affiliated investigator at the RAND Corporation.
<b> Andrew Cole, MD, FRCP(C) </b>
Andrew Cole, MD, FRCP(C) Harvard School of Public Health
Dr. Cole is a Professor of Neurology in the Department of Neurology at the Harvard Medical School. He is also the Director of the MGH Epilepsy Service and the Chief of the Division of Clinical Neurophysiology, where he directs the MGH Epilepsy Fellowship Program. He leads The MGH Epilepsy Research Laboratory, which is focused on understanding the consequences of abnormal neuronal activity and conducts multiple clinical trials to improve the care for patients with epilepsy.

“If I have seen further it is only by standing on the shoulders of giants.”

Isaac Newton